down arrow

Biomea Fusion, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09077A1060
USD
1.40
0.05 (3.7%)

Dec 19

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.301.40

52 Week

0.874.59
Valuation
Technical
Day's Volume

CASH

1.49 M

Shareholding (Mar 2025)

FII

6.87%

Held by 71 FIIs

DII

59.56%

Held by 36 DIIs

Promoter

0.14%

How big is Biomea Fusion, Inc.?

22-Jun-2025

As of Jun 18, Biomea Fusion, Inc. has a market capitalization of 108.96 million and reported net sales of 0.00 million with a net profit of -128.63 million for the latest four quarters. The company has shareholder's funds of 51.57 million and total assets of 79.94 million as of Dec 24.

Market Cap: As of Jun 18, Biomea Fusion, Inc. has a market capitalization of 108.96 million, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Biomea Fusion, Inc. reported net sales of 0.00 million and a net profit of -128.63 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 51.57 million and total assets of 79.94 million.

Read More

What does Biomea Fusion, Inc. do?

22-Jun-2025

Biomea Fusion, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $29 million and a market cap of $108.96 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -447.60%.

Overview: <BR>Biomea Fusion, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -29 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 108.96 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.20 <BR>Return on Equity: -447.60% <BR>Price to Book: 3.79<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Biomea Fusion, Inc. technically bullish or bearish?

20-Sep-2025

As of August 18, 2025, Biomea Fusion, Inc. has shifted to a mildly bearish trend, with mixed technical indicators and recent performance showing outperformance against the S&P 500 over the past week and month, but significant negative returns year-to-date and over the past year.

As of 18 August 2025, the technical trend for Biomea Fusion, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The weekly MACD and KST are mildly bullish, while the monthly MACD and KST are bearish. The moving averages are mildly bearish on a daily basis. Bollinger Bands indicate a bullish signal weekly but a mildly bearish signal monthly. Dow Theory shows a mildly bullish stance for both weekly and monthly periods. <BR><BR>In terms of performance, Biomea Fusion has outperformed the S&P 500 over the past week and month, with returns of 5.05% and 19.54%, respectively, compared to 1.05% and 2.33% for the index. However, year-to-date and one-year returns are significantly negative at -46.39% and -76.06%, respectively, against the S&P 500's positive returns of 12.22% and 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 108 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.02

stock-summary
Return on Equity

-407.46%

stock-summary
Price to Book

3.92

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.21%
0%
-28.21%
6 Months
-26.7%
0%
-26.7%
1 Year
-65.69%
0%
-65.69%
2 Years
-90.14%
0%
-90.14%
3 Years
-82.3%
0%
-82.3%
4 Years
-80.61%
0%
-80.61%
5 Years
0%
0%
0.0%

Biomea Fusion, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-251.89%
EBIT to Interest (avg)
-104.84
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.20
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
82.17%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.26
EV to EBIT
-0.45
EV to EBITDA
-0.45
EV to Capital Employed
-10.37
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-447.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 38 Schemes (33.43%)

Foreign Institutions

Held by 71 Foreign Institutions (6.87%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 44.50% vs -49.80% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-20.80",
          "val2": "-38.50",
          "chgp": "45.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-20.70",
          "val2": "-37.30",
          "chgp": "44.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -17.99% vs -43.40% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-142.30",
          "val2": "-121.90",
          "chgp": "-16.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-138.40",
          "val2": "-117.30",
          "chgp": "-17.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-20.80
-38.50
45.97%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-20.70
-37.30
44.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 44.50% vs -49.80% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-142.30
-121.90
-16.74%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-138.40
-117.30
-17.99%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -17.99% vs -43.40% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Biomea Fusion, Inc. stock-summary
stock-summary
Biomea Fusion, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."